In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers.

Discover how advanced imaging technologies are uncovering the biological mechanisms behind breast cancer treatment resistance ...

Analysts have set 12-month price targets for Illumina, revealing an average target of $106.56, a high estimate of $128.00, and a low estimate of $80.00. Witnessing a positive shift, the current ...

Genomics remains the largest platform, while single-cell multiomics and metabolomics are set for fastest growth as pharma and biotech R&D spending accelerates worldwide.Austin, Sept. 26, 2025 (GLOBE ...

The oncology-based molecular diagnostics market is being propelled by the increasing prevalence of cancer worldwide and the ...

A research group led by The University of Osaka has developed a novel method for analyzing cancer metabolism, revealing new insights into cancer's inefficient energy process. This breakthrough, ...

The freely available platform is designed to work with spatial data from various platforms and to support a broad range of analysis types.

Cancer researcher Chi Van Dang studies pharmacokinetics—the way the body absorbs, distributes, metabolizes, and excretes a ...

This is a solid paper on intermittent fasting that will be of interest to readers. The data presented are certainly valuable as a resource. The findings of both shared and tissue-specific signatures, ...

The global protein chip market revenue was US$ 652.8 million in 2020. The global protein chip market is forecast to reach US$ 1,367.1 million by 2030, growing at a compound annual growth rate (CAGR) ...